Literature DB >> 14512107

Why do so many drug users smoke?

Robert M McCool1, Kimber Paschall Richter.   

Abstract

To better understand why most persons in drug treatment smoke, we explored patients' views of the relationship between their smoking, methadone, and drug use. Recruiting from four methadone clinics, we held seven focus groups with 68 current smokers, and 10 individual interviews with former smokers. Sessions were audio-taped, transcribed, and coded. Participants were > or =18 years old, smoked > or =5 cigarettes per day, and had used prescription methadone for > or =2 years. Most patients linked smoking, methadone, and drug use in three ways. First, patients said smoking and drug use were complementary. Examples included smoking to reduce methadone after taste and using drugs to reduce smoking-related throat pain. Second, smoking and drug use were similar because they shared cues and withdrawal symptoms. Third, smoking differed from drug use because it had fewer acute consequences. Because smoking, methadone, and drug use are closely interrelated, future addictions research and treatment protocols should address them in combination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512107     DOI: 10.1016/s0740-5472(03)00065-5

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  16 in total

Review 1.  Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review.

Authors:  Sarah C Akerman; Mary F Brunette; Alan I Green; Daisy J Goodman; Heather B Blunt; Sarah H Heil
Journal:  J Subst Abuse Treat       Date:  2014-12-22

2.  Tobacco use and substance use disorders as predictors of postoperative weight loss 2 years after bariatric surgery.

Authors:  Claire E Adams; Jeanne M Gabriele; Lauren E Baillie; Patricia M Dubbert
Journal:  J Behav Health Serv Res       Date:  2012-10       Impact factor: 1.505

3.  An Open Trial of Electronic Cigarettes for Smoking Cessation Among Methadone-Maintained Smokers.

Authors:  Michael D Stein; Celeste Caviness; Kristin Grimone; Daniel Audet; Bradley J Anderson; Genie L Bailey
Journal:  Nicotine Tob Res       Date:  2015-12-28       Impact factor: 4.244

4.  Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial.

Authors:  M D Stein; C M Caviness; M E Kurth; D Audet; J Olson; B J Anderson
Journal:  Drug Alcohol Depend       Date:  2013-08-14       Impact factor: 4.492

5.  Contingent incentives reduce cigarette smoking among pregnant, methadone-maintained women: results of an initial feasibility and efficacy randomized clinical trial.

Authors:  Michelle Tuten; Heather Fitzsimons; Margaret S Chisolm; Paul A Nuzzo; Hendree E Jones
Journal:  Addiction       Date:  2012-06-21       Impact factor: 6.526

6.  E-cigarette knowledge, attitudes, and use in opioid dependent smokers.

Authors:  Michael D Stein; Celeste M Caviness; Kristin Grimone; Daniel Audet; Allison Borges; Bradley J Anderson
Journal:  J Subst Abuse Treat       Date:  2014-11-20

Review 7.  Review: the need for smoking cessation among HIV-positive smokers.

Authors:  Shadi Nahvi; Nina A Cooperman
Journal:  AIDS Educ Prev       Date:  2009-06

Review 8.  The phenomics and genetics of addictive and affective comorbidity in opioid use disorder.

Authors:  Philip J Freda; Jason H Moore; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2021-02-22       Impact factor: 4.492

9.  Motivation to quit smoking among HIV-positive smokers in Vietnam.

Authors:  Nhung Thi Phuong Nguyen; Bach Xuan Tran; Lu Y Hwang; Christine M Markham; Michael D Swartz; Jennifer I Vidrine; Huong Thu Thi Phan; Carl A Latkin; Damon J Vidrine
Journal:  BMC Public Health       Date:  2015-04-03       Impact factor: 3.295

10.  Recovery post treatment: plans, barriers and motivators.

Authors:  Paul Duffy; Helen Baldwin
Journal:  Subst Abuse Treat Prev Policy       Date:  2013-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.